Gut Microbiota: Implications in Parkinson's Disease

Overview

Journal Parkinsonism Relat Disord

Specialty Neurology

Date 2017 Feb 17

PMID 28202372

Citations 97

Authors

Arun Parashar

Malairaman Udayabanu

Affiliations

Soon will be listed here.

Abstract

Gut microbiota (GM) can influence various neurological outcomes, like cognition, learning, and memory. Commensal GM modulates brain development and behavior and has been implicated in several neurological disorders like Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, anxiety, stress and much more. A recent study has shown that Parkinson's disease patients suffer from GM dysbiosis, but whether it is a cause or an effect is yet to be understood. In this review, we try to connect the dots between GM and PD pathology using direct and indirect evidence.

Citing Articles

Gut Microbiota-Based Interventions for Parkinson's Disease: Neuroprotective Mechanisms and Current Perspective.

Kumar D, Bishnoi M, Kondepudi K, Sharma S Probiotics Antimicrob Proteins. 2025; .

PMID: 39809955 DOI: 10.1007/s12602-024-10433-x.

Gut Microbiota and Immune System Dynamics in Parkinson's and Alzheimer's Diseases.

Kustrimovic N, Balkhi S, Bilato G, Mortara L Int J Mol Sci. 2024; 25(22).

PMID: 39596232 PMC: 11595203. DOI: 10.3390/ijms252212164.

Trends and hotspots on the relationship between gut microbiota and Parkinson's Disease: a bibliometric analysis.

Li X, Hao X, Chen C, Zhai C, Pan T, Zhou X Front Cell Infect Microbiol. 2024; 14:1421270.

PMID: 39403202 PMC: 11472709. DOI: 10.3389/fcimb.2024.1421270.

Therapeutic Targets of Probiotics in Parkinson Disease: A Systematic Review of Randomized Controlled Trials.

Atak E, Yildiz D, Kocaturk R, Temizyurek A, Ozcan O, Erguzel T Basic Clin Neurosci. 2024; 15(2):165-174.

PMID: 39228448 PMC: 11367217. DOI: 10.32598/bcn.2022.3665.1.

Gut-directed therapy in Parkinson's disease.

Benvenuti L, Di Salvo C, Bellini G, Seguella L, Rettura F, Esposito G Front Pharmacol. 2024; 15:1407925.

PMID: 38974034 PMC: 11224490. DOI: 10.3389/fphar.2024.1407925.

References

Alasia D, Asekomeh G, Unachuku C . Parkinsonism induced by sepsis: a case report. Niger J Med. 2006; 15(3):333-6. DOI: 10.4314/njm.v15i3.37243. View

Miyake Y, Fukushima W, Tanaka K, Sasaki S, Kiyohara C, Tsuboi Y . Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan. Eur J Neurol. 2010; 18(1):106-13. DOI: 10.1111/j.1468-1331.2010.03088.x. View

Surwase S, Jadhav J . Bioconversion of L-tyrosine to L-DOPA by a novel bacterium Bacillus sp. JPJ. Amino Acids. 2010; 41(2):495-506. DOI: 10.1007/s00726-010-0768-z. View

Cassani E, Privitera G, Pezzoli G, Pusani C, Madio C, Iorio L . Use of probiotics for the treatment of constipation in Parkinson's disease patients. Minerva Gastroenterol Dietol. 2011; 57(2):117-21. View

Ogata A, Tashiro K, Nukuzuma S, Nagashima K, Hall W . A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol. 1997; 3(2):141-7. DOI: 10.3109/13550289709015803. View

Arai H, Furuya T, Mizuno Y, Mochizuki H . Inflammation and infection in Parkinson's disease. Histol Histopathol. 2006; 21(6):673-8. DOI: 10.14670/HH-21.673. View

Smith M, Fletcher-Turner A, Yurek D, Cass W . Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res. 2006; 31(4):533-9. DOI: 10.1007/s11064-006-9048-4. View

Pompei A, Cordisco L, Amaretti A, Zanoni S, Matteuzzi D, Rossi M . Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol. 2006; 73(1):179-85. PMC: 1797147. DOI: 10.1128/AEM.01763-06. View

Fiddian-Green R . Helicobacter pylori eradication and L-dopa absorption in patients with PD and motor fluctuations. Neurology. 2007; 68(13):1085. DOI: 10.1212/01.wnl.0000260440.07107.99. View

10.

Tan A, Mahadeva S, Thalha A, Gibson P, Kiew C, Yeat C . Small intestinal bacterial overgrowth in Parkinson's disease. Parkinsonism Relat Disord. 2014; 20(5):535-40. DOI: 10.1016/j.parkreldis.2014.02.019. View

11.

Faust K, Gehrke S, Yang Y, Yang L, Beal M, Lu B . Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease. BMC Neurosci. 2009; 10:109. PMC: 3152779. DOI: 10.1186/1471-2202-10-109. View

12.

Kosiewicz M, Zirnheld A, Alard P . Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol. 2011; 2:180. PMC: 3166766. DOI: 10.3389/fmicb.2011.00180. View

13.

Cersosimo M, Benarroch E . Pathological correlates of gastrointestinal dysfunction in Parkinson's disease. Neurobiol Dis. 2011; 46(3):559-64. DOI: 10.1016/j.nbd.2011.10.014. View

14.

Wall R, Cryan J, Ross R, Fitzgerald G, Dinan T, Stanton C . Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol. 2014; 817:221-39. DOI: 10.1007/978-1-4939-0897-4_10. View

15.

Abbott R, Petrovitch H, White L, Masaki K, Tanner C, Curb J . Frequency of bowel movements and the future risk of Parkinson's disease. Neurology. 2001; 57(3):456-62. DOI: 10.1212/wnl.57.3.456. View

16.

Neufeld K, Kang N, Bienenstock J, Foster J . Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol. 2011; 4(4):492-4. PMC: 3181531. DOI: 10.4161/cib.4.4.15702. View

17.

Fazzini E, FLEMING J, Fahn S . Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord. 1992; 7(2):153-8. PMC: 7168426. DOI: 10.1002/mds.870070210. View

18.

Shannon K, Keshavarzian A, Dodiya H, Jakate S, Kordower J . Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord. 2012; 27(6):716-9. DOI: 10.1002/mds.25020. View

19.

Browne H, Forster S, Anonye B, Kumar N, Neville B, Stares M . Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation. Nature. 2016; 533(7604):543-546. PMC: 4890681. DOI: 10.1038/nature17645. View

20.

Liu M, Bing G . Lipopolysaccharide animal models for Parkinson's disease. Parkinsons Dis. 2011; 2011:327089. PMC: 3096023. DOI: 10.4061/2011/327089. View